EFFECT OF THROMBOPOIETIN RECEPTOR AGONISTS ON COAGULATION AND PLATELET ACTIVATION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

被引：0
|
作者：
Garabet, L. [1 ]
Lee, S. [2 ]
Mowinckel, M. -C. [3 ,4 ]
Jonassen, C. [1 ]
Liebman, H. [5 ]
Bussel, J. [2 ]
Sandset, P. M. [3 ,4 ,6 ]
Ghanima, W. [7 ]
机构：
[1] Ostfold Hosp Trust, Cenetre Lab Med, Fredrikstad, Norway
[2] Weill Cornell Med Coll, Dept Pediat, Unit Platelet Disorders, New York, NY USA
[3] Univ Hosp, Internal Med Res Inst, Oslo, Norway
[4] Univ Hosp, Dept Hematol, Oslo, Norway
[5] Norris Canc Hosp & Res Inst, Dept Med, Los Angeles, CA USA
[6] Univ Hosp, Inst Clin Med, Oslo, Norway
[7] Ostfold Hosp Trust, Dept Med, Fredrikstad, Norway
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1417
引用
收藏
页码：568 / 568
页数：1
相关论文
共 50 条
  • [31] TREATMENT PATTERNS PRIOR TO THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN GERMANY
    Schill, M.
    Taieb, V
    Richter, H.
    Lebioda, A.
    VALUE IN HEALTH, 2020, 23 : S715 - S715
  • [32] Association between Acute Myelogenous Leukemia and Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia
    Oshima, Yasuo
    Yuji, Koichiro
    Tanimoto, Tetsuya
    Hinomura, Yasushi
    Tojo, Arinobu
    INTERNAL MEDICINE, 2013, 52 (19) : 2193 - 2201
  • [33] Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review
    Zhang, Jiaxing
    Liang, Yi
    Ai, Yuan
    Xie, Juan
    Li, Youping
    Zheng, Wenyi
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1543 - 1551
  • [34] Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)
    Gudbrandsdottir, Sif
    Ghanima, Waleed
    Nielsen, Claus H.
    Feng, Xingmin
    Hasselbalch, Hans C.
    Bussel, James
    PLATELETS, 2017, 28 (05) : 478 - 483
  • [35] Thrombopoietin receptor agonists in the treatment of thrombocytopenia
    Newland, Adrian
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (05) : 357 - 364
  • [36] EFFECT OF THROMBOPOIETIN-RECEPTOR AGONISTS ON CIRCULATING CYTOKINE AND CHEMOKINE LEVELS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
    Gudbrandsdottir, S.
    Ghanima, W.
    Feng, X.
    Lee, S.
    Nielsen, C.
    Hasselbalch, H.
    Bussel, J.
    HAEMATOLOGICA, 2012, 97 : 199 - 200
  • [37] Thrombopoietin receptor agonists in the treatment of immune thrombocytopenia: A clinician's perspective
    Ruggeri, Marco
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : 946 - 947
  • [38] Treatment of Immune Thrombocytopenia in Adults: The Role of Thrombopoietin-Receptor Agonists
    Rodeghiero, Francesco
    Ruggeri, Marco
    SEMINARS IN HEMATOLOGY, 2015, 52 (01) : 16 - 24
  • [39] EFFICACY AND SAFETY OF THROMBOPOIETIN RECEPTOR AGONISTS IN MODERN TREATMENT OF IMMUNE THROMBOCYTOPENIA
    Parvu, Andrada
    Orasan, Olga Hilda
    Pop, Stefan Vlad
    Zsoldos, Iulia Andrea
    Catana, Cristina
    Deac, Ioana Stefania
    Bojan, Anca Simona
    FARMACIA, 2021, 69 (02) : 219 - 230
  • [40] Management of immune thrombocytopenia in France before the era of thrombopoietin receptor agonists
    Michel, M.
    Doz, M.
    Leclerc-Teffahi, S.
    Detournay, B.
    Levy-Bachelot, L.
    REVUE DE MEDECINE INTERNE, 2012, 33 (06): : 305 - 310
12345